Sona Nanotech Stock Net Income

SNANF Stock  USD 0.19  0.00  0.00%   
Sona Nanotech fundamentals help investors to digest information that contributes to Sona Nanotech's financial success or failures. It also enables traders to predict the movement of Sona OTC Stock. The fundamental analysis module provides a way to measure Sona Nanotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sona Nanotech otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sona Nanotech OTC Stock Net Income Analysis

Sona Nanotech's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Sona Nanotech Net Income

    
  (10.37 M)  
Most of Sona Nanotech's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sona Nanotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Sona Nanotech reported net income of (10.37 Million). This is 103.04% lower than that of the Healthcare sector and 105.99% lower than that of the Diagnostics & Research industry. The net income for all United States stocks is 101.82% higher than that of the company.

Sona Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sona Nanotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Sona Nanotech could also be used in its relative valuation, which is a method of valuing Sona Nanotech by comparing valuation metrics of similar companies.
Sona Nanotech is currently under evaluation in net income category among its peers.

Sona Fundamentals

About Sona Nanotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sona Nanotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sona Nanotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sona Nanotech based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Sona OTC Stock

Sona Nanotech financial ratios help investors to determine whether Sona OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sona with respect to the benefits of owning Sona Nanotech security.